← Research Journal

Research Review

BPC-157: A Comprehensive Review of Tissue Repair Research

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a protective protein found in the stomach. This review examines the current body of preclinical research surrounding its role in tissue regeneration.

Futura Biolabs Research·June 5, 2025·8 min read

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide consisting of 15 amino acids. It is a partial sequence derived from body protection compound (BPC), a protein first isolated from human gastric juice. Since its characterisation, BPC-157 has attracted significant research interest due to its remarkable stability and cytoprotective properties.

Mechanism of Action

Research suggests BPC-157 exerts its effects through multiple pathways. Studies indicate modulation of nitric oxide (NO) production, which plays a critical role in vascular regulation and tissue repair. Additionally, BPC-157 appears to interact with the growth hormone receptor system, potentially explaining its observed effects on wound healing in preclinical models.

Several studies have examined its role in tendon-to-bone healing, demonstrating accelerated collagen synthesis and improved tensile strength in animal models. The peptide's apparent ability to upregulate growth factors including VEGF (vascular endothelial growth factor) may contribute to enhanced angiogenesis at sites of tissue injury.

Stability and Storage

From a research chemistry standpoint, BPC-157 demonstrates exceptional stability compared to many peptides of similar length. Lyophilised preparations maintain integrity at -20°C for extended periods, making it a practical compound for research protocols requiring reliable, reproducible results.

Research Applications

Current preclinical research has explored BPC-157 in the following contexts:

  • Muscle and tendon injury models
  • Gastric ulceration and gut lining integrity
  • Bone and joint healing
  • Neurological injury models
  • It is critical to note that all published research on BPC-157 has been conducted in vitro or in animal models. No peer-reviewed clinical trials in humans have been completed. All use of BPC-157 should be strictly for laboratory research purposes.

    Purity Considerations

    For research reproducibility, sourcing BPC-157 with verified purity is essential. Third-party testing via HPLC and mass spectrometry should confirm ≥99% purity. Researchers should always request and review the Certificate of Analysis (CoA) prior to use.

    This article is for informational purposes only and pertains exclusively to laboratory research applications. BPC-157 is not approved for human use.

    Research Disclaimer

    All content published by Futura Biolabs is intended for informational purposes relating to laboratory research only. The compounds discussed are not approved for human use, are not intended to diagnose, treat, cure, or prevent any disease, and should only be handled by qualified researchers in appropriate laboratory settings.